Abstract
The Fourth Annual PepTalk meeting organized by the Cambridge Healthtech Institute on proteomics was held in San Diego, California from January 10 to 13, 2005. The entire meeting had an interesting name: Proteomics in a Six- Pack, and consisted of six individual meetings that ran for two days each, in two groups of concurrent sessions: (1) Fourth Annual Protein Arrays: Complex Challenges - Creative Solutions (January 10-11); (2) Eighth Annual Protein Expression (January 10-11); (3) Inaugural Protein Folding Disorders (January 10-11); (4) Second Annual Protein Process Development: Optimizing Protein Expression Through Scale-Up (January 12-13); (5) Fifth Annual The Human Proteome: Plasma Proteomics (January 12-13); and (6) Inaugural Protein Therapeutics: Minimizing Problems - Maximizing Production, Progress, and Potential (January 12-13). This was indeed what the organizers called the “protein information week”. This report summarizes The Human Proteome meeting, which ended with a joint closing plenary session with the Protein Process Development and the Protein Therapeutics meetings.
Keywords: proteomics, human proteome, plasma proteomics
Current Proteomics
Title: Meeting Report: The Fourth Annual PepTalk Meeting: The Human Proteome
Volume: 2 Issue: 1
Author(s): Sean R. Gallagher
Affiliation:
Keywords: proteomics, human proteome, plasma proteomics
Abstract: The Fourth Annual PepTalk meeting organized by the Cambridge Healthtech Institute on proteomics was held in San Diego, California from January 10 to 13, 2005. The entire meeting had an interesting name: Proteomics in a Six- Pack, and consisted of six individual meetings that ran for two days each, in two groups of concurrent sessions: (1) Fourth Annual Protein Arrays: Complex Challenges - Creative Solutions (January 10-11); (2) Eighth Annual Protein Expression (January 10-11); (3) Inaugural Protein Folding Disorders (January 10-11); (4) Second Annual Protein Process Development: Optimizing Protein Expression Through Scale-Up (January 12-13); (5) Fifth Annual The Human Proteome: Plasma Proteomics (January 12-13); and (6) Inaugural Protein Therapeutics: Minimizing Problems - Maximizing Production, Progress, and Potential (January 12-13). This was indeed what the organizers called the “protein information week”. This report summarizes The Human Proteome meeting, which ended with a joint closing plenary session with the Protein Process Development and the Protein Therapeutics meetings.
Export Options
About this article
Cite this article as:
Gallagher R. Sean, Meeting Report: The Fourth Annual PepTalk Meeting: The Human Proteome, Current Proteomics 2005; 2 (1) . https://dx.doi.org/10.2174/1570164053507817
DOI https://dx.doi.org/10.2174/1570164053507817 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
Call for Papers in Thematic Issues
Mass spectrometry data acquisition and analysis for proteomics
The Thematic Issue on "Mass spectrometry data acquisition and analysis for proteomics" aims to explore the latest advancements and challenges in the field of proteomics through the lens of mass spectrometry. Proteomics, the large-scale study of proteins and their functions, plays a crucial role in understanding various biological processes and ...read more
Peptides: State-of-Art and Commercialisation Hurdles
The Editors of the Current Proteomics (CP) journal are highly privileged to welcome scientists to submit their scientific research and review articles to be considered for publication in the upcoming thematic issue. The topics should cover various aspects of peptides in regard to their synthetic methodologies, formulation approaches, pharmacological challenges, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Non-Steroidal LXR Agonists; An Emerging Therapeutic Strategy for the Treatment of Atherosclerosis
Recent Patents on Cardiovascular Drug Discovery Development of Genetic Testing for Breast, Ovarian and Colorectal Cancer Predisposition: A Step Closer to Targeted Cancer Prevention
Current Drug Targets Therapeutic Use of MicroRNAs in Cancer
Anti-Cancer Agents in Medicinal Chemistry Role of Caspases, Bax and Bcl-2 in Chrysin-Induced Apoptosis in the A549 Human Lung Adenocarcinoma Epithelial Cells
Anti-Cancer Agents in Medicinal Chemistry DLEU1: A Functional Long Noncoding RNA in Tumorigenesis
Current Pharmaceutical Design Thymidine Kinase-Mediated Shut Down of Bone Morphogenetic Protein-4 Expression Allows Regulated Bone Production
Current Gene Therapy Inhibition of Lysozyme by Taurine Dibromamine
Protein & Peptide Letters Potential Molecular Targets of Ampelopsin in Prevention and Treatment of Cancers
Anti-Cancer Agents in Medicinal Chemistry WT1 Peptide Vaccine as a Paradigm for “Cancer Antigen-Derived Peptide”-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide
Anti-Cancer Agents in Medicinal Chemistry Platelet-Rich Plasma Induces Mixed Osteogenic/Osteoclastogenic Phenotype in Osteosarcoma SaOS-2 Cells: Role of TGF-Beta
Current Pharmaceutical Biotechnology RECKing MMP: Relevance of Reversion-inducing Cysteine-rich Protein with Kazal Motifs as a Prognostic Marker and Therapeutic Target for Cancer (A Review)
Anti-Cancer Agents in Medicinal Chemistry Ligament and Tendon Repair through Regeneration Using Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Peptide Nucleic Acids with a Structurally Biased Backbone: Effects of Conformational Constraints and Stereochemistry
Current Topics in Medicinal Chemistry Targeting the Eph System with Peptides and Peptide Conjugates
Current Drug Targets Platinum Compounds: A Hope for Future Cancer Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Tumor Stroma Manipulation By MSC
Current Drug Targets The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Current Cancer Drug Targets Update on Cancer Related Issues of Mesenchymal Stem Cell-Based Therapies
Current Stem Cell Research & Therapy Double Layered Hydroxides as Potential Anti-Cancer Drug Delivery Agents
Mini-Reviews in Medicinal Chemistry From Peptides to Small Molecules: An Intriguing but Intricated Way to New Drugs
Current Medicinal Chemistry